XPHYF   $0.4802  11.49% Market Closed

Xphyto Therapeutics Corp
Total Cash 652.72K
totalCashPerShare 0.008
EBITDA -10.22M
Total Debt 4.92M
quickRatio 0.193
currentRatio 0.344
Total Revenue 494.77K
debtToEquity 324.275
Revenue/Share 0.006
ROA -0.77933997
ROE -5.46
grossProfits 199.48K
freeCashflow -2.98M
operatingCashflow -7.15M
earningsGrowth
revenueGrowth 11.782
grossMargins 0.68167
ebitdaMargins 0.0
operatingMargins -20.39526
profitMargins 0.0
enterpriseValue 35.19M
forwardPE
floatShares 77.25M
sharesOutstanding 73.01M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.07%
heldPercentInstitutions 0.0
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 0.051
Price To Book help_outline 5.56
earningsQuarterlyGrowth
netIncomeToCommon -14.22M
trailingEps -0.17%
forwardEps -0.19%
enterpriseToEbitda -3.44
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 0
lastUpdated Feb. 20, 2023, 4:09 a.m.